Two-pore domain potassium channel and voltage-gated potassium channel (K2P and Kv channels)

Two-pore domain potassium (K2P) channels and voltage-gated potassium (Kv) channels represent two distinct but functionally related superfamilies of ion channels essential for electrical signaling. K2P channels, such as TREK and TASK, function primarily as leak channels that set the resting membrane potential and regulate cellular excitability in response to physiological stimuli like pH, mechanical stretch, and anesthetics (Enyedi & Czirják, 2010, Physiol Rev). In contrast, Kv channels are activated by membrane depolarization and are the primary drivers of the repolarization phase of action potentials in neurons and cardiomyocytes (Kuśmierczyk & Kaczmarek, 2023, Int J Mol Sci). Both families are major therapeutic targets; Kv channels are targeted by anti-arrhythmics and anti-epileptics, while K2P channels are emerging targets for pain, depression, and respiratory disorders (Alexander et al., 2023, Guide to Pharmacology). Genetic mutations in these channels, known as channelopathies, are linked to diverse conditions including Long QT syndrome, familial migraine, and epilepsy. This entry is marked as incorrect because it combines two distinct channel families—K2P (KCNK) and Kv (KCN)—which have different structural architectures and distinct pharmacological profiles.

Other names

K2P channelsKCNK channelsLeak potassium channelsVoltage-gated potassium channelsKv channelsKCN channelsPotassium channel subfamily KVoltage-dependent potassium channels

Drugs targeting these channels act as either pore blockers to inhibit potassium efflux (e.g., Class III anti-arrhythmics) or as positive allosteric modulators and openers to enhance potassium conductance (e.g., Kv7 openers), thereby stabilizing or hyperpolarizing the membrane potential to reduce cellular excitability.